In this work, we have characterized the C-191 gene cluster (MSMEG_2851 to MSMEG_2901) of Mycobacterium smegmatis. By in silico analysis, we have identified the genes encoding enzymes involved in the modification of the A/B steroid rings during the catabolism of C-19 steroids in certain M. smegmatis mutants mapped in the PadR-like regulator (MSMEG_2868), that constitutively express the C-191 gene cluster. By using gene complementation assays, resting-cell biotransformations and deletion mutants, we have characterized the most critical genes of the cluster, that is, kstD2, kstD3, kshA2, kshB2, hsaA2, hsaC2 and hsaD2. These results have allowed us to propose a new catabolic route named C-191 pathway for the mineralization of C-19 steroids in M. smegmatis. Our data suggest that the deletion of the C-191 gene cluster may be useful to engineer more robust and efficient M. smegmatis strains to produce C-19 steroids from sterols. Moreover, the new KshA2, KshB2, KstD2 and KstD3 isoenzymes may be useful to design new microbial cell factories for the 9a-hydroxylation and/or D1-dehydrogenation of 3-ketosteroids.
Introduction
Steroids are naturally occurring hydrophobic molecules that present a structure core formed by four fused alicyclic rings named gonane. Steroid compounds are frequently found in the biosphere and can be used as carbon and energy sources by different bacteria (e.g., Mycobacterium, Pseudomonas, Sterolibacterium, Sphingomonas, Novosphingobium and Comamonas) (Fujii et al., 2002; Tarlera and Denner, 2003; Horinouchi et al., 2003a; Philipp et al., 2006; van der Geize et al., 2007; Roh and Chu, 2010; Leu et al., 2011; Merino et al., 2013) . Most bacteria capable of degrading aerobically sterols (e.g., cholesterol and phytosterols), which are one of the most abundant steroid compounds in nature, belong to the phylum Actinobacteria (e.g., Mycobacterium, Rhodococcus and Gordonia) (van der Geize et al., 2007; Kendall et al., 2007; Drzyzga et al., 2009; Uhía et al., 2012; Fern andez de las Heras et al., 2013; Li et al., 2014; Bergstrand et al., 2016) . The bacterial catabolism of cholesterol has been investigated in detail because of its relevance in the pathogenicity of certain bacteria such as Mycobacterium tuberculosis or Rhodococcus equi. These bacteria are able to metabolize cholesterol located in the membranes of the host cells during the course of infection, being the degradation of this sterol crucial for bacterial persistence (van der Geize et al., 2007; Pandey and Sassetti, 2008) . The investigation of cholesterol catabolism has also attracted increasing interest because low-cost natural sterols (e.g., phytosterols) are currently biotransformed at an industrial scale into valuable pharmaceutical steroidal intermediates such as the C-19 steroids 4-androstene-3,17-dione (AD), 1,4-androstadiene-3,17-dione (ADD) and 9a-hydroxy-4-androstene-3,17-dione (9OH-AD) Donova, 2017) .
The aerobic 9,10-seco degradation for cholesterol pathway has been postulated based on the compilation of multiple genetic and biochemical investigations carried out on different Gram-positive bacteria, but this pathway is also partially shared by some Gram-negative bacteria that degrade bile acids and testosterone (Supporting Information Fig. S1 ) (Barrientos et al., 2015; García et al., 2012; Gal an et al., 2017a) . Briefly, in Actinobacteria, the cholesterol is transported by a specific ATP-dependent transport system named Mce4 (Casali and Riley 2007; Pandey and Sassetti, 2008; Mohn et al., 2008; Klepp et al., 2012; García-Fern andez et al., 2017a) and is subsequently transformed into cholest-4-en-3-one (cholestenone) by 3b-hydroxysteroid dehydrogenase/isomerases enzymes (3b-HSD) and/or cholesterol oxidases (ChOx) (Kreit, 2017) . Concomitantly, with the formation of cholestenone, at least two P450 cytochromes, named CYP125 and CYP142, initiate the side-chain degradation by performing sequential oxidations of the methyl group at C-26 to generate a carboxylic acid (Capyk et al., 2009a; McLean et al., 2009; Rosłoniec et al., 2009; Driscoll et al., 2010; Johnston et al., 2010; Ouellet et al., 2010; García-Fern andez et al., 2013) . This modification enables the b-oxidation of the side-chain that yields two molecules of propionyl-CoA, an acetyl-CoA and the 17-ketosteroid AD (Supporting Information Fig. S1 ). Thereafter, the degradation of the A/B steroid rings of the intermediate AD occurs via a central catabolic route called 9,10-seco pathway that results in the generation of 2-hydroxyhexa-2,4.dienoic acid (HHD) and 9,17-dioxo-1,2,3,4,10,19-hexanorandrostan-5-oic acid (HIP) (Supporting Information Fig. S1 ) Gal an et al., 2017a) . The degradation of HDD probably occurs through the action of enzymes similar to the TesE, TesF and TesG proteins described in Comamonas testosteroni (Horinouchi et al., 2005) , while the degradation of HIP (i.e., the mineralization of C/D steroid rings) takes place in a lower catabolic pathway, recently studied in detail in M. tuberculosis and other Actinobacteria, which leads to the formation of metabolites that enter the central metabolic pathways (Crowe et al., 2017) . The expression of the genes responsible for the catabolism of C/D rings is controlled by the KstR2 repressor, a TetR-like transcriptional regulator (Kendall et al., 2010; Casabon et al., 2013; Crowe et al., 2015; García-Fern andez et al., 2015) , while the expression of the genes encoding the enzymes involved in the side chain and the A/B rings degradation as well as those encoding the sterol uptake system, is regulated by another TetR-like transcriptional regulator, the KstR repressor .
Conventionally, it has been proposed that the C-19 steroids AD, ADD and 9OH-AD are key intermediates of the (chole)sterol catabolic pathway due to multiple lines of evidence (Supporting Information Fig. S1 ). First, the C-19 compounds have been found in the culture medium of several naturally sterols-degrading bacteria (Marsheck et al., 1972; Wei et al., 2010) . Recently, various mutant strains producing C-19 steroids from sterols have also been constructed through metabolic engineering approaches by redirecting the metabolic flux of sterol catabolism to the accumulation of C-19 compounds by gene deletions Yeh et al., 2014; Yao et al., 2014; Gal an et al., 2017b) . In contrast, several examples of bacteria capable of using both cholesterol and C-19 steroids as the only carbon and energy source have been described (e.g., Rhodococcus erythropolis strain SQ1, Rhodococcus ruber strain Chol-4, Rhodococcus rhodochrous DSM 43269, Gordonia neofelifaecis NRRL B-59395; van der Geize et al., 2000; Petrusma et al., 2011; Fern andez de las Heras et al., 2012; Li et al., 2014) . However, these bacterial strains have other sets of steroid-degrading enzymes, different from those participating in the cholesterol catabolism, that are specifically induced by different C-19 steroids. Therefore, in these strains, the different steroid catabolic pathways could be partially overlapped creating a complex network of metabolic intermediates that are degraded by a battery of redundant enzymes that have possibly led to some misinterpretations of the pathways for sterol catabolism.
In a previous article, we proposed that the C-19 steroids AD, ADD and 9OH-AD are not the natural intermediates of the (chole)sterol catabolic pathway based on several lines of evidence (Fern andez-Cabez on et al., 2017). First, different authors showed that certain modifications introduced into the A/B rings during the catabolism of cholesterol (e.g., 9a-hydroxylation and D 1 -dehydrogenation) might occur simultaneously with the side-chain degradation. The enzymes involved in these catabolic steps appear to use as preferred substrates the acyl-CoA derivatives resulting from the b-oxidation of the side-chain (i.e., most probably compounds that still retain 3 or more carbons of the sterol side-chain) (Capyk et al., 2011; Penfield et al., 2014) . Second, by inhibiting the B-ring opening during the degradation of cholesterol, it is possible to detect in the culture medium, in addition to the C-19 steroids, other steroid intermediates that still retain part of the side-chain such as 3-oxo-23,24-bisnorchol-1,4-dien-22-oic acid (1,4-BNC), 3-oxo-23,24-bisnorchol-4-en-22-oic acid (4-BNC), 22-hydroxy-23,24-bisnorchol-1,4-dien-3-one (1,4-HBC) and 22-hydroxy-23,24-bisnorchol-4-en-3-one (4-HBC) (Szentirmai, 1990; Donova et al., 2005; Wilbrink et al., 2011; Yeh et al., 2014; Gal an et al., 2017b) . Third, we demonstrated that the C-19 steroids AD, ADD and 9OH-AD cannot be efficiently mineralized through the cholesterol pathway in Mycobacterium smegmatis mc 2 155, since neither the wildtype strain nor its unregulated mutant DkstR are able to degrade efficiently these compounds (Fern andez-Cabez on et al., 2017). All these results reinforce the hypothesis that certain modifications introduced into the A/B rings of cholesterol occur simultaneously with the side-chain degradation, and therefore, the C-19 steroids AD, ADD or 9OH-AD are actually side products of the cholesterol catabolic route (Supporting Information Fig. S1 ).
In contrast, we also reported the existence of a new silent and tightly regulated catabolic pathway in M. smegmatis, that is not induced by sterols (e.g., cholesterol and phystosterols) nor by C-19 steroids (e.g., AD, ADD and 9OH-AD), but which, after its desilencing/activation, confers to this bacterium the capacity to mineralize these and other C-19 steroids (Fern andez-Cabez on et al., 2017). The activation of this catabolic pathway is found in some M. smegmatis spontaneous mutants mapped in the PadR-like regulator (MSMEG_2868) that acquire the ability to efficiently metabolize C-19 steroids. The PadR inactivation allows the expression of a set of genes named C-191 cluster (MSMEG_2851 to MSMEG_2901) that encode putative steroid-degrading enzymes. The C-191 cluster would have evolved independently from the upper cholesterol kstR-regulon, since C-191 cluster has an independent regulation, but both C-191 cluster and kstRregulon would converge on the lower cholesterol kstR2-regulon responsible for the metabolism of C/D steroid rings (Supporting Information Fig. S1 ). However, this is only a working hypothesis that requires further confirmation. Other steroid-degrading Actinobacteria have homologous C-191 clusters (e.g., Mycobacterium neoaurum ATCC 25795, Rhodococcus jostii RHA1, Gordonia neofelifaecis NRRL-B59395 and Nocardioides simplex VKM Ac-2033D), but it is interesting to note that it is absent in M. tuberculosis and in certain industrial mycobacterial strains used to produce C-19 steroids from sterols (e.g., Mycobacterium sp. NRRL B-3805) (Fern andez-Cabez on et al., 2017) .
In this work, we have characterized in more detail the C-191 gene cluster in M. smegmatis. Using different methodologies, we have investigated the biological function and/or the essentiality of those genes of the C-191 cluster that encode the enzymes involved in the modification of A/B rings during the catabolism of C-19 steroids in this bacterium.
Results
Identification of the key genes involved in the degradation of C-19 steroids in M. smegmatis Based on the knowledge of the 9,10-seco pathway for the bacterial catabolism of steroids Gal an et al., 2017a) , we have proposed a catabolic route named C-191 pathway for the catabolism of C-19 steroids in M. smegmatis (Fig. 1A) (Fern andez-Cabez on et al., 2017) . By in silico analysis, we identified in the C-191 gene cluster homologous genes for almost all the postulated enzymatic steps involved in the A/B steroid ring modification (Fig.  1B) . The members of the kstR regulon involved in the cholesterol catabolism in M. smegmatis have been used as reference genes Uhía et al., 2012) . As shown in Fig. 1B , despite the existence of homologous genes in the two steroid catabolic gene clusters found in M. smegmatis, they do not share any synteny.
The genes MSMEG_2867 (kstD2) and MSMEG_2869 (kstD3) encode putative 3-ketosteroid-D1-dehydrogenases sharing a 36% and 44% protein identity to KstD1 (MSMEG_5941) respectively. The MSMEG_2893 (kshB2) gene encodes a putative reductase component of a 3-ketosteroid-9a-hydroxylase showing 55% protein identity to KshB1 (MSMEG_6039), whereas the MSMEG_2870 (kshA2) gene would encode the oxygenase component of the same enzyme since it has a 59% protein identity to KshA1 (MSMEG_5925). The MSMEG_2892 (hsaA2) and MSMEG_2891 (hsaC2) genes may encode a 3-HSA monooxygenase (oxygenase component) and a 3,4-HSA dioxygenase, that share between 40% and 50% protein identity to HsaA1 (MSMEG_6038) and HsaC1 (MSMEG_6036) respectively. Finally, the MSMEG_2900 (hsaD2) gene encodes a putative 4-9-DSHA hydrolase with 41% protein identity to HsaD1 (MSMEG_6037). There are not homologous genes to the hsaB1 (MSMEG_6035), hsaE (MSMEG_5940), hsaF (MSMEG_5939) and hsaG (MSMEG_5937) genes within the C191 cluster.
Determination of the biological function of the kstD2, kstD3, kshA2 and kshB2 genes To investigate the role of the MSMEG_2893 (kshB2) gene, the mutant M. smegmatis MS6039 (DMSMEG_6039, DkshB1) was complemented in trans with an original copy of the kshB2 gene. Gal an and colleagues (2017b) previously demonstrated that the MS6039 mutant is unable to efficiently grow in sterols as the sole carbon and energy source, unlike the wild-type strain of M. smegmatis, since the mutant lacks the KshB1 reductase activity necessary to mineralize cholesterol. Analogously, to study the biological function of the MSMEG_2867 (kstD3) and MSMEG_2869 (kstD2) genes, the mutant M. smegmatis MS5941 (DMSMEG_5941, DkstD1) was constructed and complemented in trans with an original copy of the kstD2 or kstD3 genes (Supporting Information Table S2 ). The KstD1 activity required to mineralize cholesterol is eliminated in the MS5941 mutant, and thus, this mutant is unable to efficiently grow in sterols as the sole carbon and energy ( Fig. 2A) . However, when the MS5941 mutant is cultured in minimal media containing glycerol as carbon and energy source and cholesterol (or phytosterols) as feedstock, a large accumulation of 9OH-AD is observed (data not shown). According to our hypothesis, the expression of a kshB gene (e.g., kshB1 and kshB2) or a kstD gene (e.g., kstD1, kstD2 and kstD3) in the MS6039 or MS5941 mutants, respectively, will restore its capability to grow in cholesterol. For this purpose, the MSMEG_2867 (kstD3), MSMEG_2869 (kstD2) and MSMEG_2893 (kshB2) genes were cloned into the pMV261 plasmid generating the corresponding recombinant plasmids pMV2867 (harbouring kstD3), pMV2869 (harbouring kstD2) and pMV2893 (harbouring kshB2). The recombinant plasmids pMV5941 (harbouring kstD1) and pMV6039 (harbouring kshB1) were also constructed and used as controls for the complementation experiments. The plasmids harbouring the kshB genes were transformed in the MS6039 mutant (DkshB1), whereas the plasmids harbouring the kstD genes were transformed into the MS5941 mutant (DkstD1). Homologous genes are shown with the same color. Gene annotation: MSMEG_(number). Protein identities are indicated in parentheses. Abbreviations of enzymes: 3-ketosteroid-D1-dehydrogenase (KstD); 3-ketosteroid-9a-hydroxylase (KshAB); 3-HSA monooxygenase (HsaAB); 3,4-HSA dioxygenase (HsaC); (4,9-DSHA) hydroxylase (HsaD); 2-hydroxy-2,4-hexadienoic acid hydratase (HsaE); 4-hydroxy-2-hydroxy-2-ketovalerate aldolase (HsaF) and acetaldehyde dehydrogenase (HsaG). Abbreviations of metabolites: 4-androstene-3,17-dione (AD); 1,4-androstadiene-3,17-dione (ADD); 9a-hydroxy-4-androstene-3,17-dione (9OH-AD); 9a-hydroxy-1,4-androstadiene-3,17-dione (9OH-ADD); 3-hydroxy-9,10-secoandrosta-1,3,5(10)-trien-9,17-dione (3-HSA); 3,4-dihydroxy-9,10-secoandrosta-1,3,5(10)-trien-9,17-dione (3,4-HSA); 4,5,9,10-diseco-3-hydroxy-5,9,7-trioxoandrosta-1(10),2-diene-4-oic acid (4,9-DSHA); 2-hydroxy-2,4-hexadienoic acid (HHD) and 3aa-H-4a ( A. Gene complementation of MS5941 (DMSMEG_5941, DkstD1) mutant: mc 2 155 (pMV261) (wt, black); MS5941 (pMV261) (MS5941, red); MS5941 (pMV5941) (KstD1, blue); MS5941 (pMV2869) (KstD2, green) and MS5941 (pMV2867) (KstD3, grey). B. Gene complementation of the MS6039 (DMSMEG_6039, DkshB1) mutant: mc 2 155 (pMV261) (wt, black); MS6039 (pMV261) (MS6039, red); MS6039 (pMV6039) (KshB1, blue) and MS6039 (pMV2893) (KshB2, green). [Colour figure can be viewed at wileyonlinelibrary.com]
The overexpression of the kstD2 gene in the MS5941 strain restored its capability of growing in cholesterol as the sole carbon and energy source, exhibiting a similar growth pattern to the wild-type strain mc 2 155 and to the MS5941 (pMV5941) that is complemented with the kstD1 gene ( Fig. 2A) . Otherwise, the overexpression of the kstD3 gene in the MS5941 (pMV2867) recombinant did not restore the ability of MS5941 of growing in cholesterol, suggesting that KstD3 present another enzymatic activity or a different substrate specificity. To investigate this hypothesis, we monitored the bioconversion of several steroid substrates by resting-cell biotransformation using the recombinant MS5941 (pMV2867). Figure 3A shows that this recombinant was able to transform AD into ADD, whereas the control strain MS5941 (pMV261) harbouring the empty plasmid was not able to, confirming that KstD3 present 3-ketosteroid-D1-dehydrogenase activity. In contrast, the overexpression of the kshB2 gene in the MS6039 strain restored its capability of growing in 1.8 mM cholesterol as the sole carbon and energy source ( Fig. 2B and Supporting Information Table S2 ). The growth of this recombinant strain MS6039 (pMV2893) was similar to the wild-type strain mc 2 155 and to the MS6039 (pMV6039) that is complemented with the kshB1 gene. Finally, to investigate the activity of MSMEG_2870 (kshA2) gene, we constructed the plasmid pMV2870 (harbouring kshA2) and followed the same resting cell approach. As expected, the recombinant strain MS5941 (pMV2870) that produces constitutively the KshA2 protein, was able to transform AD into 9OH-AD ( Fig. 3B and Supporting Information Table S2 ).
These results confirmed that the kshA2 and kshB genes encode the oxygenase subunit (KshA) and the ferredoxin reductase subunit (KshB) of a 3-ketosteroid-9a-hydroxylase enzyme, while the kstD2 and kstD3 genes encode 3-ketoesteroid-D1-dehydrogenase proteins.
Determination of the biological function of the hsaA2, hsaC2 and hsaD2 genes To investigate the biological role of the hsaA2 (MSMEG_2892), hsaC2 (MSMEG_2891) and hsaD2 (MSMEG_2900) genes in the catabolism of C-19 steroids in M. smegmatis, we constructed by double homologous recombination three mutant strains in M. smegmatis ADD1 named MS2891 (DhsaC2), MS2892 (DhsaA2) and MS2900 (DhsaD2) ( Table 1 ). The three engineered mutants were unable to efficiently grow in C-19 steroids (e.g., 1.8 mM AD) as the sole carbon and energy source when compared with the parental strain ADD1 (Fig. 4A) , although they perfectly grew using glycerol as a carbon source (data not shown). Interestingly, a color alteration of the C-19 steroid-containing medium was observed during the culture of the MS2891 and MS2900 mutants (Fig. 4B) . A pink coloration of the medium was developed in the culture of the MS2891 mutant (DhsaC2), possibly indicating the accumulation of a catecholic derivate (e.g., 3,4-HSA) and its subsequent non-enzymatic oxidation to quinone derivatives. This phenotype was previously observed in DhsaC mutants of the cholesterol catabolism in R. jostii RHA1 and M. tuberculosis H37Rv (van der Geize et al., 2007; Yam et al., 2009) , as well as in the DtesB mutant of C. testosteroni TA441 in the presence of ADD or cholic acid (Horinouchi et al., 2004b) . In contrast, a yellowishbrown coloration in the medium was observed in the culture of the MS2900 mutant (DhsaD2) likely due to the accumulation of 4,9-HSA (Gibson et al., 1966) . This characteristic color was also described in the mutant DtesD of C. testosteroni TA441 in the presence of testosterone (Horinouchi et al., 2003b) .
To confirm the absence of polar effects, the three mutant strains were complemented in trans with an original copy of the corresponding deleted gene (MSMEG_2891, MSMEG_2892 or MSMEG_2900). For that, each gene was cloned into the pMV261 plasmid generating the recombinant plasmids pMV2891, pMV2892 and pMV2900 and, then, they were transformed into the mutant strains MS2891, MS2892 and MS2900 respectively (Table 1 ). Figure 5B shows that the complemented MS2891 and MS2900 mutants (MS2891c and MS2900c, respectively) recovered the capacity to grow in C-19 steroids as the sole carbon and energy source (e.g., 1.8 mM AD) (Supporting Information Table S2 ). In contrast, the complemented MS2892 strain (MS2892c) was not able to grow in 1.8 mM AD as the sole carbon and energy source, although it showed a normal growth in other substrates (e.g., 18 mM glycerol) (Fig. 5A) . However, the same pink coloration in the AD-containing medium described above with the MS2891 mutant was also observed in the culture broths of MS2892c strain (Fig. 5C ). This result supports the hypothesis that the MSMEG_2892 gene encodes a 3-HSA monooxygenase, which under overexpression conditions, could generate high amounts of 3,4-HSA to inhibit bacterial growth. The high toxicity of these compounds to the cells has been previously described (Yam et al., 2009 ). Our results confirmed that the hsaA2, hsaC2 and hsaD2 genes play an essential role in the catabolism of C-19 (Fig. 1A) . According to the classical 9,10-seco pathway, the transformation of AD into ADD is the first enzymatic step necessary for the opening of A/B rings for the aerobic catabolism of steroids. This reaction is catalyzed by 3-ketosteroid-D1-dehydrogenases named KstD in M. smegmatis (Brzostek et al., 2005) , R. erythropolis (van der Geize et al., 2000; and M. tuberculosis (Brzostek et al., 2009 ), but named TesH in C. testosteroni (Horinouchi et al., 2003a) . The 3-ketosteroid-D 1 -dehydrogenase are FAD-dependent proteins that catalyze the trans-axial removal of the hydrogen atoms C-1(a) and C-2(b) of 3-ketosteroids (EC 1.33.99.4) (Knol et al., 2008) . We have demonstrated that the KstD2 protein is able to replace the biological role of KstD1 in the catabolism of cholesterol in M. smegmatis MS5941 (DMSMEG_5941, DkstD1) (at least, under the tested conditions of kstD2 gene overexpression), even though KstD2 is not involved in the catabolism of sterols in this bacterium ( Fig. 2A) . This result agrees with the previous findings of Brzostek and colleagues (2005) . In contrast, the overexpresssion of the kstD3 gene (MSMEG_2867) in the MS5941 mutant is not able to restore this capability ( Fig. 2A) , although the KstD3 protein has 3-ketosteroid-D 1 -dehydrogenase activity in resting-cell biotransformations (Fig. 3A) . This result suggests that KstD3 is not able to efficiently recognize the intermediates with side chain that are possibly the true substrates of KstD1 during the cholesterol catabolism (Fern andez-Cabez on et al., 2017).
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Then, the 9a-hydroxylation step takes place by the action of the 3-ketosteroid-9a-hydroxylases (Andor et al., 2006; van der Geize et al., 2007; Capyk et al., 2009b) . These enzymes are two-component monooxygenases consisting of a terminal oxygenase subunit (KshA) and a ferredoxin reductase subunit (KshB) (EC 1.14.13.142) (Petrusma et al., 2014) . The KshA subunit specifically recognizes the steroid substrates, whereas the KshB component transfers the reducing power required for the progression of the enzymatic reaction. Petrusma and colleagues (2011) described the presence of five kshA genes involved in the catabolism of different classes of steroids (e.g., cholesterol, cholate, AD and progesterone) in R. rhodochrous DSM43269, each displaying unique steroid induction patterns and substrate ranges. They demonstrated that the overexpression of only certain kshA genes in a null-kshA mutant restores its growth on any of the different classes of steroids tested. The KshA/KshB interaction does not seem to be very specific, since it is possible to find more kshA genes than kshB genes in the genomes of actinobacterial species (e.g. R. jostii RHA1, N. simplex VKM Ac-2033D and G. neofelifaecis NRRL B-59395) . This observation suggests that a particular KshB protein can interact with several KshAs or even that other nonspecific reductases present in the bacterial cell can act as donors of reducing power. In agreement with this observation, we have demonstrated that the KshB2 of M. smegmatis is able to replace KshB1 in the catabolism of cholesterol (Fig. 2B ). In the same line, Yuan and colleagues (2015) were able to reconstitute a functional KSH in Mycobacterium sp. NRRL B-3805 by overexpressing the kshA gene of M. smegmatis and the kshB gene of G. neofelifaecis NRRL B-59395. Moreover, we have observed that the co-expression of a kshB gene does not seem to be always essential for the 9a-hydroxylations of 3-ketosteroids (Fig.  3B) , as previously demonstrated by other authors (Andor et al., 2006; Arnell et al., 2007) .
The 3-HSA intermediate obtained after the action of the 3-ketosteroid-D 1 -dehydrogenase and the 3-ketosteroid-9a-hydroxylase enzymes, is hydroxylated by a two-component oxygenase (HsaA2B1), similar to TesA1A2 from C. testosteroni (Horinouchi et al., 2004b) or to HsaAB from M. tuberculosis and R. jostii RHA1 (Dresen et al., 2010) leading to the production of 3,4-DHSA. This catechol derivative is subsequently cleaved by a meta-extradiol dioxygenase (HsaC2), similar to TesB in C. testosteroni (Horinouchi et al., 2001) or to HsaC in R. jostii RHA1 (van der Geize et al., 2007) and M. tuberculosis H37Rv (Yam et al., 2009) , that yields 4,9-DSHA. This compound is subsequently hydrolyzed by a meta-cleavage product (MCP) hydrolase (HsaD2) similar to TesD in C. testosteroni (Horinouchi et al., 2003b) or to HsaD in M. tuberculosis and R. jostii RHA1 (van der Geize et al., 2007; Lack et al., 2008; yielding HIP and HHD. To investigate the biological role of the HsaA2, HsaC2 and HsaD2 proteins in the catabolism of C-19 steroids, in this article we have constructed by double homologous recombination the mutants ADD1 MS2891 (DMSMEG_2891; DhsaC2), ADD1 MS2892 (DMSMEG_2892; DhsaA2) and ADD1 MS2900 (DMSMEG_2900; DhsaD2). The three mutants are unable to efficiently grow in C-19 steroids as the sole carbon and energy source, confirming that the hsaA2, hsaC2 and hsaD2 genes are essential for the catabolism of C-19 steroids in M. smegmatis (Fig. 4A) . Moreover, the color changes of culture media observed when the mutant strains are cultured in the presence of C-19 compounds strongly support the C-191 pathway postulated above.
Finally, the degradation of HDD should occur through the action of the enzymes HsaE, HsaF and HsaG encoded by the unique hsaEFG operon of M. smegmatis (Fern andezCabez on et al., 2017). These genes are not always present in all steroid-degrading gene clusters in Actinobacteria, because they encode enzymes that are common in many catabolic pathways of aromatic compounds, and thus, these enzymes can replace those (Bergstrand et al., 2016) .
In summary, the results presented above confirm that the C-19 steroids AD, ADD and 9OH-AD are mineralized through the C-191 catabolic pathway that is constitutively expressed in the padR mutants of M. smegmatis. Although we have identified some of the key enzymatic steps of the C-191 pathway, additional studies are required to determine the roles of other genes found in the C-191 gene cluster of M. smegmatis (MSMEG_2851 to MSMEG_2901), as well as to identify the chemical compound that induces this cluster in vivo. A better understanding of the complexity of steroid catabolism in M. smegmatis and other actinobacterial species can also be fundamental to optimize the current industrial bioproduction of steroidal intermediates from sterols. The deletion of the C-191 gene cluster or at least of the most relevant genes located therein (e.g., kstD, kshA and kshB) will be useful to increase the bioconversion yields in producer strains derived from M. smegmatis and other cholesterol degrading bacteria. Yao and colleagues (2014) demonstrated that two residual enzymatic activities KstD (KstD2 and KstD3) present in the mutant Mut(MN-KSTD1) (DkstD1) of M. neoaurum ATCC 25795, markedly decreases the conversion yield of 9OH-AD from sterols. Interestingly, KstD2 and KstD3 are encoded by genes located in a homologous C-191 cluster that is not found in the close phylogenetic strains M. neoaurum VKM Ac-1815D and Mycobacterium sp. NRRL B-3805, both used in industrial bioprocesses. In contrast, given the industrial relevance of the 9a-hydroxylation and D1-dehydrogenation reactions of 3-ketosteroids, the new KshA2, KshB2, KstD2 and KstD3 enzymes identified could be used to design new microbial cell factories for the production of steroids a la carte.
Experimental procedures
Chemicals 4-Androstene-3,17-dione (AD) and 1,4-androstadien-3,17-dione (ADD) were purchased from TCI America. Cholesterol, Tween 80, tyloxapol, gentamicin and kanamycin were from Sigma (Steinheim, Germany). Glycerol and glucose were purchased from Merck (Darmstardt, Germany). 9a-Hydroxy-4-androstene-3,17-dione (9OH-AD) was kindly provided by Gadea Biopharma (Le on, Spain).
Bacterial strains, plasmids and culture conditions
The plasmids and bacterial strains used in this work are listed in Table 1 ), were used for strain selection when appropriate. All the steroids were dissolved in 10% tyloxapol prior to its addition to the minimal medium. Because of the low solubility of the steroid compounds, the stock solutions were warmed at 808C in agitation, sonicated in a bath for 1 h and then autoclaved.
Escherichia coli DH10B strain was used as a host for cloning. It was grown in LB medium at 378C in an orbital shaker at 200 r.p.m. LB agar plates were used for solid media. Kanamycin (50 mg ml 21 ) or gentamicin (10 mg ml 21 ) were used for plasmid selection and maintenance.
DNA manipulations and sequencing
DNA manipulations and other molecular biology techniques were essentially as described by Sambrook and Russell (2001) . Oligonucleotides used at this work were purchased from Sigma-Aldrich and are listed in Supporting Information Table S1 . Genomic DNA purification from mycobacterial strains was performed as previously described . DNA amplification was performed on a Mastercycler Gradient (Eppendorf) using Phusion High-Fidelity DNA Polymerase from ThermoFisher Scientific. DNA fragments were purified with High Pure PCR System Product Purification Kit (Roche). Restriction enzymes were obtained from various suppliers and were used according to their specifications. Plasmid DNA was prepared with a High Pure Plasmid Isolation Kit (Roche Applied Science). E. coli was transformed by the rubidium chloride method (Wirth et al., 1989) . M. smegmatis cells were transformed by electroporation (Gene Pulser; Bio-Rad) (Parish and Stoker, 1998) . All cloned inserts and DNA fragments were confirmed by DNA sequencing through an ABI Prism 377 automated DNA sequencer (Applied Biosystems Inc.) at Secugen S.L. (Madrid, Spain).
Gene deletion
The knock-out strains were constructed by double homologous recombination using the plasmid pJQ200x, a derivative of the suicide vector pJQ200 that does not replicate in Mycobacterium (Jackson et al., 2001) . The followed approach consisted in amplifying by PCR two fragments of 700 bp containing the upstream region (UP fragment) and the downstream region (DOWN fragment) of the target gene to be deleted (Supporting Information Table S1 ). The two PCR fragments were purified, digested with the corresponding enzymes and ligated. Using the ligation product as template, the UP 1 DOWN fragment was amplified by PCR using the most external primers. The resulting amplicon was cloned into the plasmid pJQ200x using E. coli DH10B competent cells. Then, the resulting pJQ200x-derivate plasmid was electroporated into competent M. smegmatis ADD1 (Table 1 ). The single cross-overs were selected on 7H10 agar plates containing gentamicin. The obtained single colonies were contraselected in 10% sucrose and in addition, the presence of the xylE gene marker was confirmed by the appearance of yellow coloration after spreading catechol over each colony replica. To select for double cross-overs, a single colony was grown in rich medium up to an optical density of 0.8-0.9 and several dilutions of this culture were plated onto 7H10 agar plates with 10% sucrose. Potential double cross-overs (i.e., sucroseresistant colonies) were subsequently screened for gentamicin sensitivity and the gene deletion was confirmed by PCR.
Complementation of the knock-out mutants
To isolate the genes (e.g., MSMEG_2891) from M. smegmatis mc 2 155 for the complementation experiments, its genomic DNA was extracted and amplified by PCR using the corresponding primers forward and reverse (e.g., MSMEG_2891F and MSMEG_2891R) (Supporting Information Table S1 ). The resulting amplicons were purified and digested with the corresponding restriction enzymes to be cloned into the expression vector pMV261 (Stover et al., 1991) , a shuttle plasmid that replicates in E. coli and Mycobacterium. The resulting plasmids (e.g., pMV2891) were transformed into E. coli DH10B for cloning purposes and once their sequences were verified, they were used to transform electrocompetent cells of the corresponding M. smegmatis mutant strain (e.g., MS2891). The mutant strains harbouring the plasmid pMV261were used as controls.
Resting-cell biotransformations
The recombinant strains were grown in rich medium at 378C during 24 h. The cells were harvested by centrifugation at 5000 3 g for 20 min at 48C and washed once with 0.85% NaCl. The biotransformation was carried out with an optical density (OD 600 ) of 5 in a 100 ml shake flask containing 40 ml of reaction mixture: 0.1 M phosphate buffer (pH 8.0), 2 mM AD (substrate) and 0.05% Tween 80. An additional carbon source (1% glucose) was added in the 9alpha-hydroxylation biotransformations. The substrate AD was incorporated into the medium as a solution with randomly methylated bcyclodextrin (1:10.3, molar ratio) (Klein et al., 1995) or alternatively, was dissolved in 10% tyloxapol as mentioned above. The steroid bioconversion was monitored by thin layer chromatography (TLC) .
Bioinformatic analysis
Sequence alignments were carried out using Clustal W (Thompson et al., 1994) and different BLAST algorithms from the National Centre of Biotechnology Information Server (NCBI) were also used.
Supporting information
Additional Supporting Information may be found in the online version of this article at the publisher's web-site: Table S1 . Oligonucleotides used in this study. Table S2 . Summary of the M. smegmatis mutant's phenotype used in this work and its complementation. Fig. S1 . Scheme of the cholesterol catabolic pathway conventionally proposed in Actinobateria. The cholesterol pathway has been traditionally considered to take place through three consecutive stages. First, the sidechain degradation and 3b-dehydrogenation of the cholesterol molecules occurs in the upper catabolic pathway apparently yielding two molecules of propionyl-CoA, an acetyl-CoA and the 17-ketosteroid AD. Then, the modification of A/B rings of AD in the central catabolic pathway leads to the generation of the HHD and HIP acids. This last compound is mineralized through the lower catabolic pathway. The expression of the genes encoding the enzymes involved in the side chain and the A/B rings degradation, as well as those encoding the sterol uptake system, is regulated by the KstR repressor (kstR regulon), while the expression of the genes responsible for the catabolism of C/D rings is controlled by the KstR2 repressor (kstR2 regulon). Abbreviations of enzymes: 3-ketosteroid-D1-dehydrogenase (KstD); 3-ketosteroid-9a-hydroxylase (KshAB); 3-HSA monooxygenase (HsaAB); 3,4-HSA dioxygenase (HsaC) and (4,9-DSHA) hydroxylase (HsaD). Abbreviations of metabolites: 4-androstene-3,17-dione (AD); 1,4-androstadiene-3,17-dione (ADD); 9a-hydroxy-4-androstene-3,17-dione (9OH-AD); 9a-hydroxy-1,4-androstadiene-3,17-dione (9OH-ADD); 3-hydroxy-9,10-secoandrosta-1,3,5(10)-trien-9,17-dione (3-HSA); 3,4-dihydroxy-9,10-secoandrosta-1,3,5(10)-trien-9,17-dione (3,4-HSA); 4,5,9,10-diseco-3-hydroxy-5,9,7-trioxoandrosta-1(10),2-diene-4-oic acid (4,9-DSHA); 2-hydroxyhexa-2,4.dienoic acid (HHD) and 3aa-H4a(3 0 -propionic acid)-7ab-methylhexahydro-1,5-indanedione (HIP). Fig. S2 . Chemical structures of relevant steroidal intermediates detected in the culture medium of several naturally sterols-degrading bacteria. Abbreviations: AD (4-androstene-3,17-dione); ADD (1,4-androstadiene-3,17-dione); 9OH-AD (9a-hydroxy-4-androstene-3,17-dione); 4-HBC (22-hydroxy-23,24-bisnorchol-4-en-3-one); 1,4-HBC (22-hydroxy-23,24-bisnorchol-1,4-dien-3-one); 4-BNC (3-oxo-23,24-bisnorchol-4-en-3-oic acid) and 1,4-BNC (3-oxo-23,24-bisnorchol-1,4-dien-3-oic acid). 
